Results 101 to 110 of about 11,861 (217)

Patient-Reported Impact of Symptoms in Spinal and Bulbar Muscular Atrophy. [PDF]

Neurol Clin Pract, 2023
Alqahtani A, Kokkinis A, Zizzi C, Dilek N, Fischbeck KH, Heatwole CR, Grunseich C.   +6 more
europepmc   +1 more source

Molecular-targeted therapy for spinal and bulbar muscular atrophy (SBMA)

Rinsho Shinkeigaku, 2010
Spinal and bulbar muscular atrophy (SBMA) is an adult-onset neurodegenerative disease characterized by slowly progressive muscle weakness and atrophy. The cause of SBMA is the expansion of a trinucleotide CAG repeat, which encodes the polyglutamine tract, within the first exon of the androgen receptor (AR) gene.
openaire   +3 more sources

The value of serum creatinine as biomarker of disease progression in spinal and bulbar muscular atrophy (SBMA). [PDF]

Sci Rep, 2023
Blasi L, Sabbatini D, Fortuna A, Querin G, Martinelli I, Vianello S, Bertolin C, Pareyson D, Pennuto M, Pegoraro E, Bello L, Sorarù G.   +11 more
europepmc   +1 more source

An Interdomain Interaction of the Androgen Receptor Is Required for Its Aggregation and Toxicity in Spinal and Bulbar Muscular Atrophy

, 2020
Christopher R. Orr, Heather L. Montie, Yuhong Liu, Elena Bolzoni, Shannon C. Jenkins, Elizabeth M. Wilson, James D. Joseph, Donald P. McDonnell, Diane E. Merry   +8 more
openalex   +1 more source

Development of a functional composite for the evaluation of spinal and bulbar muscular atrophy. [PDF]

Sci Rep, 2022
Inagaki T, Hashizume A, Hijikata Y, Yamada S, Ito D, Kishimoto Y, Torii R, Sato H, Hirakawa A, Katsuno M.   +9 more
europepmc   +1 more source

Mexiletine in spinal and bulbar muscular atrophy: a randomized controlled trial. [PDF]

Ann Clin Transl Neurol, 2022
Yamada S, Hashizume A, Hijikata Y, Inagaki T, Ito D, Kishimoto Y, Kinoshita F, Hirakawa A, Shimizu S, Nakamura T, Katsuno M.   +10 more
europepmc   +1 more source

Bicalutamide and Trehalose Ameliorate Spinal and Bulbar Muscular Atrophy Pathology in Mice. [PDF]

Neurotherapeutics, 2023
Galbiati M, Meroni M, Boido M, Cescon M, Rusmini P, Crippa V, Cristofani R, Piccolella M, Ferrari V, Tedesco B, Casarotto E, Chierichetti M, Cozzi M, Mina F, Cicardi ME, Pedretti S, Mitro N, Caretto A, Risè P, Sala A, Lieberman AP, Bonaldo P, Pennuto M, Vercelli A, Poletti A.   +24 more
europepmc   +1 more source

Ligand Promotes Intranuclear Inclusions in a Novel Cell Model of Spinal and Bulbar Muscular Atrophy

, 2002
Jessica L. Walcott, Diane E. Merry
openalex   +1 more source

Disrupted Transforming Growth Factor-β Signaling in Spinal and Bulbar Muscular Atrophy [PDF]

, 2010
Masahisa Katsuno, Hiroaki Adachi, Makoto Minamiyama, Masahiro Waza, Hideki Doi, Naohide Kondo, Hiroyuki Mizoguchi, Atsumi Nitta, Kiyofumi Yamada, Haruhiko Banno, Keisuke Suzuki, Fumiaki Tanaka, Gen Sobue   +12 more
openalex   +1 more source

Advancing Epidemiology and Genetic Approaches for the Treatment of Spinal and Bulbar Muscular Atrophy: Focus on Prevalence in the Indigenous Population of Western Canada. [PDF]

Genes (Basel), 2023
Wilton-Clark H, Al-Aghbari A, Yang J, Yokota T, Yokota T.   +4 more
europepmc   +1 more source